Main
>
RHEUMATOLOGY>RHEUMATOID ARTHRITIS
>
Treatment
>
p38 MAP Kinase Inhibitor Program
>
Compound (Co.: USA. Arr.)
>
Market: Oral Active Etanercept
Market: Oral Active Etanercept's products
This section has no products